Get 2023 health coverage. Health Insurance Marketplace®
Get 2023 health coverage. Health Insurance Marketplace®
Related Articles
Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability‐Free Survival in Older People | Journal of the American Heart Association
BackgroundThe risk–benefit balance of statin use in healthy older people is uncertain. We describe the baseline characteristics of the STAREE (Statins in Reducing Events in…
GitHub – andrewyng/aisuite: Simple, unified interface to multiple Generative AI providers
Simple, unified interface to multiple Generative AI providers – GitHub – andrewyng/aisuite: Simple, unified interface to multiple Generative AI providers
A Survey on LLM-as-a-Judge
Accurate and consistent evaluation is crucial for decision-making across numerous fields, yet it remains a challenging task due to inherent subjectivity, variability, and scale. Large…
MRI-Proven Incident Ischemia: A New Marker of Disease Progression in Small Vessel Diseases | Stroke
BACKGROUND: In ischemic cerebral small vessel diseases (cSVD), recurrent ischemic stroke is rare (2%–3% per year). Because acute ischemia may not always lead to stroke…
Boston Scientific to Acquire Intera Oncology – Endovascular Today
November 25, 2024—Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Intera Oncology Inc. Boston Scie
Happy 2nd birthday, ChatGPT! Here are 5 ways you’ve already changed the world
Here’s to everyone’s best friend/mentor/sous-chef/criminal accomplice
Transcatheter Tricuspid Valve Replacement:
AbstractTranscatheter tricuspid valve replacement (TTVR) has emerged as a promising intervention for the treatment of severe tricuspid regurgitation with complex valve morphology. This consensus do…
Celebrate 50 Years of ASE in 2025
Over the last 50 years, ASE has emerged as a highly regarded professional organization and is the largest cardiac subspecialty organization in the world. Our…
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
Generic Victoza® is the first-ever generic GLP-1 and supports increased demand for this category of therapies in the U.S. market. This launch adds to Teva’s…
Associations of Circulating Platelet Endothelial Cell Adhesion Molecule‐1 Levels With Progression of Cerebral Small‐Vessel Disease, Cognitive Decline, and Incident Dementia | Journal of the American Heart Association
BackgroundThe association between platelet endothelial cell adhesion molecule‐1 (PECAM‐1) with cerebral small‐vessel disease and cognition in dementia‐free subjects remains uninvestigated.Methods a…